Michael Pflughoft
Physician Assistant · Oklahoma City, OKNPI 1023080223
Payments from drug & device makers
Across 184 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$762
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$475
- AbbVie$432
- Johnson & Johnson$300
- Corium, LLC$280
- Otsuka America Pharmaceutical, Inc.$275
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,55795%
- Education$1875%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 34 | $762 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $475 |
| AbbVie | 27 | $432 |
| Johnson & Johnson | 14 | $300 |
| Corium, LLC | 11 | $280 |
| Otsuka America Pharmaceutical, Inc. | 13 | $275 |
| Alkermes, Inc. | 13 | $240 |
| Nalu Medical, Inc. | 1 | $143 |
| Lundbeck LLC | 9 | $129 |
| Merck | 8 | $124 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Indivior Inc. | 7 | $115 |
| Vanda Pharmaceuticals Inc. | 6 | $95 |
| Sunovion Pharmaceuticals Inc. | 4 | $80 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Ironshore Pharmaceuticals Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 2 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$143
- Azstarys$124
- Austedo XR$123
- TZIELD$122
- AUSTEDO$122
- CAPLYTA$116
- SPRAVATO$115
- VRAYLAR$111
How this compares
$3,744 in reported general payments places this provider in the 85th percentile of 1,491 physician assistant providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 28 | $284 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Oklahoma City
- Jennifer SmithOklahoma City$134K
- Sarah HawkOklahoma City$23K
- Brooke CromerOklahoma City$14K
- Mary Jane RorickOklahoma City$14K
- Alma HintzeOklahoma City$14K
- Emily McLainOklahoma City$13K
- Deniz AktasOklahoma City$13K
- Jovonne SmithOklahoma City$12K
- Anthony SharpOklahoma City$11K
- Whitney PriceOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.